Kane Akai
Analyst
Chardan
Equibles does not estimate personal net worth.
About Kane Akai
Kane Akai is recorded as Analyst at Chardan. Kane Akai has spoken on 1 investor event across 1 company, most recently for Wave Life Sciences, Inc. on October 20, 2026. The companies whose calls Kane Akai spoke on are classified in the Healthcare sector.
Kane Akai on recent calls
“Thank you, I want to welcome you to this session, RNA Medicines, Next Generation, RNA Therapeutics. My name is Kane Akai, I'm the Director of Research and one of the Senior Biotech Analysts at Chardon.”
Affiliation history
-
Chardan
Analyst
Transcript header (unverified)
Current